cyfluthrin has been researched along with erythromycin in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 85 (93.41) | 29.6817 |
2010's | 3 (3.30) | 24.3611 |
2020's | 3 (3.30) | 2.80 |
Authors | Studies |
---|---|
Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
Brueggemann, AB; Doern, GV; Huynh, HK; Rhomberg, PR; Wingert, EM | 1 |
Hammerschlag, MR; Reznik, T; Roblin, PM; Strigl, S | 1 |
Cao, Z; Capobianco, JO; Flamm, RK; Ma, Z; Shortridge, VD; Zhong, P | 1 |
Appelbaum, PC; Davies, TA; Ednie, LM; Hoellman, DM; Jacobs, MR; Pankuch, GA | 1 |
Boyea, N; Danziger, LH; Hackleman, JM; Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, K; Warren, Y | 1 |
Araujo, FG; Craft, JC; Khan, AA; Remington, JS | 1 |
Carter, JL; Cynamon, MH; Shoen, CM | 1 |
Nord, CE; Sillerström, E; Wahlund, E | 1 |
Andrews, JM; Ashby, JP; Walker, RM; Weller, TM; Wise, R | 1 |
Appelbaum, PC; Bajaksouzian, S; Credito, KL; Jacobs, MR; Lin, G; Pankuch, GA | 1 |
Appleman, MD; Citron, DM | 1 |
Muller-Serieys, C | 1 |
Barrett, JF; Dougherty, TJ | 1 |
Champney, WS; Tober, CL | 2 |
Bryskier, A | 1 |
Craft, JC | 1 |
Biedenbach, DJ; Jones, RN; Rospide, MF | 1 |
Hoban, DJ; Nichol, K; Wierzbowski, AK; Zhanel, GG | 1 |
Almer, L; Beyer, J; Bui, MH; Flamm, RK; Hensey-Rudloff, D; Ma, Z; Nilius, AM; Or, YS | 1 |
Citron, DM; Conrads, G; Goldstein, EJ; Merriam, CV; Tyrrell, K; Warren, Y | 1 |
Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A | 1 |
de Azavedo, J; Gourdeau, M; Laverdiere, M; Low, DE; Quach, C; Restieri, C; Rubin, E; Weiss, K | 1 |
Brade, V; Hunfeld, KP; Kekoukh, E; Kraiczy, P; Molitor, M; Wichelhaus, TA | 1 |
Edelstein, MA; Edelstein, PH; Higa, F | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Su, WG; Wu, YJ | 1 |
Lawrence, LE | 1 |
Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
Danziger, LH; Neuhauser, MM; Pendland, SL; Prause, JL | 2 |
Malathum, K; Murray, BE; Singh, KV | 1 |
Benjamin, WH; Crain, MC; Edwards, KM; Gray, BM; Johnson, CN; Waites, KB | 1 |
Peters, G; von Eiff, C | 1 |
Kim, M; Nicolau, DP; Nightingale, CH; Xuan, D; Ye, M | 1 |
Almer, LS; Beyer, JM; Cao, Z; Doktor, SZ; Flamm, RK; Ramer, NC; Shortridge, VD; Zhong, P | 1 |
Casellas, JM; Gliosca, L; Tomé, G; Visser, M | 1 |
Astfalk, N; Jagusch, H; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
Neuhauser, MM; Pendland, SL; Prause, JL | 2 |
Flamm, RK; Hensey-Rudloff, DM; Nilius, AM; Reimann, MA | 1 |
Danziger, LH; Jung, R; Pendland, SL | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Schwarz, S; Verhoef, J | 1 |
Finegold, SM; Molitoris, D; Phan, VT; Vaisanen, ML; Wexler, HM | 1 |
Champney, WS; Pelt, J | 1 |
Cortes, L; Guilbault, C; Low, DE; Restieri, C; Weiss, K | 1 |
Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W | 1 |
Ma, Z; Nilius, AM | 1 |
Astfalk, N; Köhrer, K; Petridou, J; Scheuring, S; Schmitz, FJ; Schwarz, S | 1 |
Danziger, LH; Jung, R; Neuhauser, MM; Pendland, SL | 1 |
Champney, WS | 1 |
Shortridge, V; Zhong, P | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Crabb, DM; Duffy, LB; Waites, KB | 1 |
Barson, WJ; Bradley, JS; Kaplan, SL; Lamberth, LB; Mason, EO; Wald, ER | 1 |
Allewelt, M; Bulitta, J; Burkhardt, O; Lode, H; Pletz, MW; Preechachatchaval, V | 1 |
Bartels, H; Franceschi, F; Hansen, HA; Harms, JM; Schlünzen, F; Yonath, A; Zarivach, R | 1 |
Conejo, Mdel C; Martínez-Martínez, L; Pascual, A; Perea, EJ; Suárez, AI | 1 |
Bukofzer, S; Hammerschlag, MR; Ramirez, J; Reznik, T; Roblin, PM; Summersgill, J | 1 |
Bellyou, T; Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
Almaraz, F; Baquero, F; Cantón, R; del Campo, R; Loza, E; Morosini, MI | 1 |
Ballesta, S; del Castillo, C; García, I; Pascual, A; Perea, EJ | 1 |
Berisio, R; Fucini, P; Hansen, HA; Harms, J; Schluenzen, F; Yonath, A; Zarivach, R | 1 |
Besier, S; Brade, V; Giesser, I; Hunfeld, KP; Schäfer, V; Wichelhaus, TA | 1 |
Arntzen, L; Bukofzer, S; Frean, J; Klugman, KP | 1 |
Murray, BE; Pai, SR; Singh, KV | 1 |
Fukano, H; Matsushima, T; Miyashita, N; Niki, Y; Yoshida, K | 1 |
Conte, JE; Lin, ET; Ren, Q; Zurlinden, E | 1 |
Banevicius, MA; Capitano, B; Maglio, D; Nicolau, DP; Nightingale, CH | 1 |
Hisanaga, T; Hoban, DJ; Nichol, K; Wierzbowski, A; Zhanel, GG | 1 |
Alvirez-Freites, E; Cynamon, MH; DeStefano, MS; Yeo, AE | 1 |
Acker, G; Brade, V; Hunfeld, KP; Kraiczy, P; Rödel, R; Wichelhaus, TA | 1 |
Crawford, SA; Jorgensen, JH; McElmeel, ML; Whitney, CG | 1 |
Abdelghaffar, H; Babin-Chevaye, C; Labro, MT | 1 |
Bukofzer, S; Cassar, SC; Driscoll, RM; Gentile, MC; Gordon, EF; Grimm, DR; Gustavson, LE; Katz, DA; O'dea, RF; Polzin, JE; Rieser, MJ; Williams, LA; Ye, X | 1 |
Chávez-Bueno, S; Fonseca-Aten, M; Gómez, AM; Hardy, RD; Hatfield, J; Jafri, HS; Katz, K; McCracken, GH; Mejías, A; Ramilo, O; Ríos, AM | 1 |
Conte, JE; Golden, JA; Kipps, J; Zurlinden, E | 1 |
Cao, Z; Capobianco, JO; Flamm, RK; Merta, P; Nilius, AM; Ruan, X; Zhong, P | 1 |
Champney, WS; Mentens, N; Zurawick, K | 1 |
Korkhin, Y; Mankin, AS; Xiong, L | 1 |
Allen, MS; Christesen, AC; Henry, RF; Hollis, LS; Keyes, R; Marsden, I; Rehm, TC; Shiroor, SG; Soni, NB; Stewart, KD; Stoner, EJ | 1 |
Bosnar, M; Eraković, V; Kelnerić, Z; Munić, V; Parnham, MJ | 1 |
Azoulay-Dupuis, E; Barau, C; Bédos, JP; Fantin, B; Mohler, J | 1 |
Dinos, GP; Kalpaxis, DL; Krokidis, MG; Márquez, V; Wilson, DN | 1 |
Cao, L; Chen, X; Du, D; Liu, J; Zheng, Z | 1 |
An, PH; Li, MS; Linh, HQ; Nguyen, HL; Thai, NQ | 1 |
Min, YH | 1 |
Chen, Z; Deng, X; Fang, Y; Hu, Y; Li, D; Ouyang, L; Xu, H; Yu, Z; Zhang, H; Zheng, J | 1 |
9 review(s) available for cyfluthrin and erythromycin
Article | Year |
---|---|
[Ketolides and oxazolidinones. Mechanisms of action and antibacterial spectrum].
Topics: Acetamides; Anti-Bacterial Agents; Erythromycin; Gram-Positive Bacterial Infections; Humans; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Respiratory Tract Infections; Streptococcus; Structure-Activity Relationship | 2000 |
ABT-773: a new ketolide antibiotic.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides | 2001 |
Ketolides-telithromycin, an example of a new class of antibacterial agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Gram-Positive Cocci; Humans; Ketolides; Macrolides | 2000 |
ABT-773 overview.
Topics: Animals; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Humans; Ketolides; Ribosomes; Staphylococcus; Streptococcus | 2001 |
Recent developments on ketolides and macrolides.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Drug Design; Drug Evaluation, Preclinical; Erythromycin; Ketolides; Ketones; Macrolides; Structure-Activity Relationship | 2001 |
ABT-773 (Abbott Laboratories).
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Erythromycin; Humans; Ketolides; Respiratory Tract Infections; Structure-Activity Relationship | 2001 |
Bacterial ribosomal subunit synthesis: a novel antibiotic target.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Erythromycin; Ketolides; Macrolides; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomal Proteins; Ribosomes | 2001 |
The emerging new generation of antibiotic: ketolides.
Topics: Anti-Bacterial Agents; Binding Sites; Drug Design; Erythromycin; Ketolides; Macrolides; Ribosomes; RNA, Ribosomal, 23S | 2001 |
Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
4 trial(s) available for cyfluthrin and erythromycin
Article | Year |
---|---|
ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate.
Topics: Adult; Anti-Ulcer Agents; Area Under Curve; Biological Assay; Chromatography, Liquid; Cross-Over Studies; Drug Interactions; Erythromycin; Female; Humans; Ketolides; Male; Mass Spectrometry; Microbial Sensitivity Tests; Ranitidine; Sucralfate | 2003 |
Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Adult; Aged; Chlamydia Infections; Chlamydophila pneumoniae; Double-Blind Method; Erythromycin; Female; Humans; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
Topics: Adolescent; Adult; Aged; Area Under Curve; Confidence Intervals; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Genes, MDR; Genotype; Humans; Ketolides; Male; Middle Aged; Statistics, Nonparametric | 2004 |
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Bacteria; Biological Assay; Bronchoalveolar Lavage Fluid; Bronchoscopy; Erythromycin; Female; Half-Life; Humans; Ketolides; Lung; Male; Middle Aged; Prospective Studies; Pulmonary Alveoli; Respiratory Mucosa; Specimen Handling | 2004 |
78 other study(ies) available for cyfluthrin and erythromycin
Article | Year |
---|---|
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae | 2000 |
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
Topics: Chlamydia Infections; Chlamydophila pneumoniae; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests | 2000 |
Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Drug Resistance, Microbial; Erythromycin; Ketolides; Ribosomes; Streptococcus pneumoniae | 2000 |
Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
Topics: Anti-Bacterial Agents; Erythromycin; Ketolides; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 2000 |
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2000 |
Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections | 2000 |
Ketolide ABT-773 is active against Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Erythromycin; Female; Humans; Ketolides; Mice; Toxoplasma; Toxoplasmosis | 2000 |
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
Topics: Animals; Anti-Bacterial Agents; Cell Count; Clarithromycin; Erythromycin; Ketolides; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 2000 |
In vitro activity of ABT-773 against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests | 2000 |
The in vitro activity of ABT773, a new ketolide antimicrobial agent.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests | 2000 |
Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
Topics: Anti-Bacterial Agents; Erythromycin; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Time Factors | 2001 |
Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests | 2001 |
Structure-activity relationships for six ketolide antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Microbial; Erythromycin; Gene Expression; Ketolides; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomal Proteins; Ribosomes; Staphylococcus aureus; Structure-Activity Relationship | 2001 |
Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gram-Positive Cocci; Haemophilus influenzae; Humans; Ketolides; Macrolides; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2001 |
Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Canada; Drug Resistance, Microbial; Erythromycin; Gene Frequency; Humans; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple; Enterococcus; Erythromycin; Helicobacter pylori; Humans; Ketolides; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Time Factors | 2001 |
In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Erythromycin; Humans; Ketolides; Maxillary Sinus; Microbial Sensitivity Tests; Pneumococcal Infections; Punctures; Sinusitis | 2001 |
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
In vitro susceptibility of the Borrelia burgdorferi sensu lato complex to ABT-773, a novel ketolide.
Topics: Borrelia burgdorferi; China; Erythromycin; Germany; Humans; Ketolides; Microbial Sensitivity Tests; Netherlands; Pilot Projects; Switzerland; United States | 2001 |
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Guinea Pigs; Ketolides; Legionella pneumophila; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Outcome | 2001 |
In vitro activity of the ketolide ABT-773.
Topics: Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2001 |
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Positive Cocci; Ketolides; Microbial Sensitivity Tests; Virginiamycin | 2001 |
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2001 |
Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Staphylococcus | 2002 |
Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach.
Topics: Administration, Oral; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Erythromycin; Female; Half-Life; Intestinal Absorption; Ketolides; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neutropenia; Respiratory Tract Infections; Tissue Distribution | 2002 |
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Ribosomes; Staphylococcus; Streptococcus | 2002 |
In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2002 |
Molecular characterization of ketolide-resistant erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Mutation; Staphylococcus aureus; Virginiamycin | 2002 |
In vitro bactericidal activity of ABT-773 and amoxicillin against erythromycin-susceptible and -resistant strains of Streptococcus pyogenes.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Ketolides; Microbial Sensitivity Tests; Penicillins; Streptococcus pyogenes | 2002 |
Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Culture Media; Erythromycin; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Infections; Rifampin; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2002 |
Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Ketolides; Legionella pneumophila; Microbial Sensitivity Tests | 2002 |
In vitro bactericidal activity and post-antibiotic effect of ABT-773 versus co-amoxiclav against anaerobes.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacteria, Anaerobic; Bacteroides fragilis; Drug Therapy, Combination; Erythromycin; Ketolides; Kinetics; Microbial Sensitivity Tests; Peptostreptococcus | 2002 |
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus | 2002 |
Activities of ABT-773 against microaerophilic and fastidious organisms.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Erythromycin; Ketolides; Microbial Sensitivity Tests | 2002 |
The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; In Vitro Techniques; Ketolides; Macrolides; Pneumococcal Infections; Protein Biosynthesis; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae | 2002 |
Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Female; Genes, Bacterial; Genotype; Humans; Ketolides; Macrolides; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Quebec; Streptococcus pneumoniae | 2002 |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2002 |
Ketolides: the future of the macrolides?
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Methyltransferases; Ribosomes | 2002 |
Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the noninducers quinupristin, telithromycin, or ABT-773.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Protein Biosynthesis; Selection, Genetic; Staphylococcus aureus; Virginiamycin | 2002 |
In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Erythromycin; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2002 |
Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes.
Topics: Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Phenotype; Streptococcus pneumoniae | 2002 |
In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Mycoplasma | 2003 |
In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
Topics: Anti-Bacterial Agents; Erythromycin; Ketolides; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 2003 |
Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Erythromycin; Haemophilus influenzae; Humans; Inhibitory Concentration 50; Ketolides; Macrolides; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Ribosomes | 2003 |
In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Culture Media; Drug Therapy, Combination; Erythromycin; Humans; Ketolides; Kinetics; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Structural basis for the antibiotic activity of ketolides and azalides.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Ketolides; Ribosomes; RNA, Ribosomal; Structure-Activity Relationship | 2003 |
Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.
Topics: Anti-Bacterial Agents; Clindamycin; Corynebacterium; Erythromycin; Humans; Ketolides; Listeria monocytogenes; Microbial Sensitivity Tests | 2003 |
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Humans; Indoles; Ketolides; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Tigecycline | 2003 |
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gram-Negative Bacterial Infections; Haemophilus influenzae; Humans; Influenza, Human; Ketolides; Longitudinal Studies; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moraxella catarrhalis; Respiratory Tract Infections; Tigecycline | 2003 |
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
Topics: Anti-Bacterial Agents; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes.
Topics: 2,4-Dinitrophenol; Antimetabolites; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Separation; Cell Survival; Centrifugation, Density Gradient; Erythromycin; Humans; Hydrogen-Ion Concentration; Ketolides; Kinetics; Neutrophils; Staphylococcus aureus; Temperature; Uncoupling Agents | 2003 |
Structural insight into the antibiotic action of telithromycin against resistant mutants.
Topics: Anti-Bacterial Agents; Binding Sites; Crystallization; Crystallography, X-Ray; Deinococcus; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Macrolides; Models, Molecular; Molecular Sequence Data; RNA, Ribosomal, 23S | 2003 |
Selection of ketolide resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; In Vitro Techniques; Ketolides; Macrolides; Mutation; Selection, Genetic; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactamases; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Ketolides; Microbial Sensitivity Tests | 2003 |
In vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis model.
Topics: Animals; Colony Count, Microbial; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Ketolides; Lethal Dose 50; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis | 2003 |
In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Erythromycin; Humans; Japan; Ketolides; Macrolides; Microbial Sensitivity Tests | 2003 |
A high-performance liquid chromatographic-tandem mass spectrometric method for the determination of cethromycin (ABT-773) in human plasma, bronchoalveolar lavage fluid, and alveolar cells.
Topics: Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Erythromycin; Humans; Ketolides; Pulmonary Alveoli; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Female; Immunocompetence; Ketolides; Mice; Mice, Inbred CBA; Neutropenia; Neutrophils; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2003 |
In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Nocardia; Sampling Studies; Sensitivity and Specificity | 2004 |
Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Borrelia burgdorferi; Erythromycin; Humans; Ketolides; Lyme Disease; Macrolides; Microbial Sensitivity Tests | 2004 |
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; North America; Pneumococcal Infections; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2004 |
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro.
Topics: Anti-Bacterial Agents; Cell Differentiation; Cell Line; Cell Survival; Culture Media; Erythromycin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ketolides; Neutrophils; Oxidants; Phagocytes; Subcellular Fractions; Temperature | 2004 |
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Topics: Airway Obstruction; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cephalosporins; Chemokines; Cytokines; Erythromycin; Ketolides; Lung; Mice; Mycoplasma pneumoniae; Plethysmography; Pneumonia, Mycoplasma; Respiratory Mechanics; Respiratory Tract Infections | 2004 |
Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Erythromycin; Gene Expression Regulation, Bacterial; Haemophilus influenzae; Humans; Ketolides; Protein Biosynthesis; Ribosomes; RNA, Ribosomal, 23S; Transcription, Genetic | 2004 |
An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2004 |
Binding site of the bridged macrolides in the Escherichia coli ribosome.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Binding, Competitive; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Ribosomes; RNA, Ribosomal, 23S | 2005 |
An unusual intramolecular hetero-Diels-Alder cycloaddition.
Topics: Catalysis; Crystallography, X-Ray; Cyclization; Erythromycin; Ketolides; Molecular Conformation; Molecular Structure; Stereoisomerism | 2005 |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dogs; Epithelial Cells; Erythromycin; Humans; Ketolides; Macrolides; Mice; Neutrophils; Phagocytes | 2005 |
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Ketolides; Mice; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2006 |
Insights into the mode of action of novel fluoroketolides, potent inhibitors of bacterial protein synthesis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Erythromycin; Escherichia coli; Ketolides; Microbial Sensitivity Tests; Protein Biosynthesis; Ribosomes; RNA, Ribosomal, 23S | 2014 |
Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.
Topics: Anti-Bacterial Agents; Azithromycin; Carbamates; Erythromycin; Haemophilus influenzae; Ketolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes | 2016 |
Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
Topics: Binding Sites; Entropy; Erythromycin; Escherichia coli; Hydrogen Bonding; Ketolides; Macrolides; Methylation; Molecular Docking Simulation; Molecular Dynamics Simulation; Ribosomes; Static Electricity; Thermodynamics; Time Factors; Triazoles | 2019 |
Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gene Expression Regulation, Bacterial; Genes, Reporter; Genetic Engineering; Ketolides; Lac Operon; Lincosamides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Miocamycin; Staphylococcus aureus; Streptogramin B; Transformation, Bacterial; Triazoles | 2020 |
The antimicrobial activity of cethromycin against Staphylococcus aureus and compared with erythromycin and telithromycin.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Lincosamides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B | 2023 |